Trials / Recruiting
RecruitingNCT05821075
Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy
Comparative Study Between Prednisolone, Cerebrolysin in the Treatment of Bell's Palsy
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- October 6 University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Bell's palsy, a peripheral facial nerve paresis, is the most common disorder of the facial nerve and one of the most common mononeuropathies. Many patients with Bell's palsy will develop some complications such as synkinesis, crocodile tears and 'sweating' of the ear while eating Commonly used medications to treat Bell's palsy is Corticosteroids Cerebrolysin stimulates the regeneration of the nervous tissue with protective action we aim to study the efficacy of cerebrolycin in Bell's palsy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prednisolone | prednisolone 60mg tablet once daily for 5 days then tapering dose |
| DRUG | Cerebrolysin | intramuscular Cerebrolysin 10 mg daily for 3 weeks |
Timeline
- Start date
- 2023-08-24
- Primary completion
- 2026-01-01
- Completion
- 2026-02-01
- First posted
- 2023-04-20
- Last updated
- 2025-07-31
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05821075. Inclusion in this directory is not an endorsement.